BioSpace News Archive

Novocure announced it has opened a new office in Montreal to expand and support its growing business in Canada.

Scholar Rock today announced that the company granted equity awards as a material inducement to an employee hired by Scholar Rock in November 2022.

BiondVax Pharmaceuticals Ltd. congratulates the company’s co-lead scientific research collaborator Professor Dr. Dirk Görlich, director at the Max Planck Institute for Multidisciplinary Sciences (MPI), on being awarded the inaugural $1.4 million World Laureates Association (WLA) Prize in Life Sciences or Medicine for his seminal work describing protein transport within the cell.

Sera Prognostics Inc. today announced the publication of results from a clinical utility and cost-effectiveness modeling study, ACCORDANT (Analyses aCross Congruent studies ReDucing Adverse pregNancy ouTcomes).

Epic Bio today announced that the company will be participating in the BMO Virtual Spotlight Series: Epigenome Editing, on November 21, 2022.

Neogen Corporation announced that it has launched its trusted Synergize® disinfectant in Europe, the Middle East, and Africa.

Neutron Therapeutics and Cosylab announced that they have reached their second joint milestone in the clinical commissioning of Neutron Therapeutics’ nuBeam® BNCT System, utilizing Cosylab’s OncologyOne software, at Helsinki University Hospital – implementation of a complete treatment workflow on a patient model.

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal year 2023 on Tuesday, November 22, 2022.

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company”), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases,

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is pleased to announce the continued evolution of its patented Automated Cell Therapy System (ACTS).